Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations
- PMID: 14623723
- DOI: 10.1001/archneur.60.11.1524
Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations
Abstract
Chronic neuropathic pain, caused by lesions in the peripheral or central nervous system, comes in many forms. We describe current approaches to the diagnosis and assessment of neuropathic pain and discuss the results of recent research on its pathophysiologic mechanisms. Randomized controlled clinical trials of gabapentin, the 5% lidocaine patch, opioid analgesics, tramadol hydrochloride, and tricyclic antidepressants provide an evidence-based approach to the treatment of neuropathic pain, and specific recommendations are presented for use of these medications. Continued progress in basic and clinical research on the pathophysiologic mechanisms of neuropathic pain may make it possible to predict effective treatments for individual patients by application of a pain mechanism-based approach.
Comment in
-
Pain 2003.Arch Neurol. 2003 Nov;60(11):1520. doi: 10.1001/archneur.60.11.1520. Arch Neurol. 2003. PMID: 14623721 No abstract available.
Similar articles
-
Therapeutic management of chronic neuropathic pain: an examination of pharmacologic treatment.Ann N Y Acad Sci. 2006 Nov;1088:164-86. doi: 10.1196/annals.1366.016. Ann N Y Acad Sci. 2006. PMID: 17192564 Review.
-
Mechanisms and treatment of neuropathic pain.Cent Nerv Syst Agents Med Chem. 2009 Mar;9(1):71-8. doi: 10.2174/187152409787601932. Cent Nerv Syst Agents Med Chem. 2009. PMID: 20021340
-
Elucidation of pathophysiology and treatment of neuropathic pain.Cent Nerv Syst Agents Med Chem. 2012 Dec;12(4):304-14. doi: 10.2174/187152412803760645. Cent Nerv Syst Agents Med Chem. 2012. PMID: 23033930 Review.
-
[Pharmacological management of neuropathic pain].Therapie. 2019 Dec;74(6):633-643. doi: 10.1016/j.therap.2019.04.003. Epub 2019 Apr 13. Therapie. 2019. PMID: 31097329 French.
-
Management of neuropathic pain.Curr Opin Support Palliat Care. 2007 Aug;1(2):126-31. doi: 10.1097/SPC.0b013e3282eeb45f. Curr Opin Support Palliat Care. 2007. PMID: 18685353 Review.
Cited by
-
Measuring GABAergic inhibitory activity with TMS-EEG and its potential clinical application for chronic pain.J Neuroimmune Pharmacol. 2013 Jun;8(3):535-46. doi: 10.1007/s11481-012-9383-y. Epub 2012 Jun 29. J Neuroimmune Pharmacol. 2013. PMID: 22744222 Review.
-
Relation between injury of the periaqueductal gray and central pain in patients with mild traumatic brain injury: Observational study.Medicine (Baltimore). 2016 Jun;95(26):e4017. doi: 10.1097/MD.0000000000004017. Medicine (Baltimore). 2016. PMID: 27368020 Free PMC article.
-
Brain morphological alternation in chronic pain patients with neuropathic characteristics.Mol Pain. 2016 Jun 8;12:1744806916652408. doi: 10.1177/1744806916652408. Print 2016. Mol Pain. 2016. PMID: 27284013 Free PMC article.
-
Active immunization with myelin-derived altered peptide ligand reduces mechanical pain hypersensitivity following peripheral nerve injury.J Neuroinflammation. 2015 Feb 13;12:28. doi: 10.1186/s12974-015-0253-4. J Neuroinflammation. 2015. PMID: 25885812 Free PMC article.
-
Gut microbiota regulates neuropathic pain: potential mechanisms and therapeutic strategy.J Headache Pain. 2020 Aug 17;21(1):103. doi: 10.1186/s10194-020-01170-x. J Headache Pain. 2020. PMID: 32807072 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources